← Back to Search


Static Magnetic and Electric (sBE) device for Glioblastoma

Waitlist Available
Research Sponsored by Varun Monga, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up during the initial 8 weeks of treatment
Awards & highlights


This trial will study whether it is safe and feasible to use a home-based device that applies static magnetic and electric fields for 8 hours during sleep in adults with recurrent glioblastoma at their first relapse.

Eligible Conditions
  • Glioblastoma (GBM)
  • Glioblastoma


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the initial 8 weeks of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the initial 8 weeks of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events according to CTCAE v5.0
Greater than or equal to 80% sBE compliance as determined by device pressor sensors, participant reporting via daily diary, and participant completion of sBE Device Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Group I: Patients: sBE device applied during sleep, in combination with Lomustine and BevacizumabExperimental Treatment3 Interventions
The sBE device is to be used 8 hours a day by the patients, during sleep, for 8 weeks, while also receiving standard chemotherapy Lomustine and Bevacizumab
Group II: Partners of Patients (who sleep in same bed): sBEExperimental Treatment1 Intervention
Up to 12 associated unaffected partners may agree to sleep within the investigational sBE device congruent with the period of exposure of their rGBM partner (8 weeks + possible extension)
First Studied
Drug Approval Stage
How many patients have taken this drug
FDA approved
FDA approved

Find a Location

Who is running the clinical trial?

Varun Monga, MDLead Sponsor
6 Previous Clinical Trials
136 Total Patients Enrolled
1 Trials studying Glioblastoma
10 Patients Enrolled for Glioblastoma
University of IowaOTHER
455 Previous Clinical Trials
882,135 Total Patients Enrolled
2 Trials studying Glioblastoma
203 Patients Enrolled for Glioblastoma
~0 spots leftby Aug 2026